GlassScriptPhysician profile
Elischa Brown
NPI 1184032989
$1,276.36
in general payments reported to CMS, 2019-2025
15 companies · $15.09 in 2025
The $15.09 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $507 · 2022: $377 · 2023: $317 · 2024: $60.53 · 2025: $15.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $499.05 | 2021-2023 | Senza |
| Forte Bio-Pharma LLC | $146.73 | 2021-2023 | Prolate, Nalocet |
| Abbvie INC. | $119.90 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.68 | 2022-2023 | Relistor |
| Medtronic, INC. | $81.97 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $71.54 | 2022 | |
| Almatica Pharma LLC | $70.00 | 2021 | |
| Boston Scientific Corporation | $39.38 | 2024 | Varithena Administration Pack |
| Biodelivery Sciences International, INC. | $37.57 | 2021 | |
| Collegium Pharmaceutical, INC. | $32.34 | 2021 | |
| Scilex Pharmaceuticals INC. | $16.99 | 2023 | Ztlido |
| Exact Sciences Corporation | $15.09 | 2025 | The Cologuard Plus Collection Kit |
| Stimwave Technologies Incorporated | $14.86 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.11 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elischa Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.